Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 12/20 | 0.53 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.53 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.53 |
| ▸ | BCHE | P06276 | 4/20 | 0.53 |
| ▸ | ACHE | P22303 | 4/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.53 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | THPO | P40225 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5210678 | 0.84 | ALDH1A1 (0.52) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL5537563 | 0.82 | L3MBTL1 (0.54) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL7440647 | 0.82 | MTNR1A (0.59) | ALDH1A1KDM4EHPGD | |
| SCHEMBL5547134 | 0.81 | TAS1R3 (0.45) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL28674154 | 0.80 | ALDH1A1 (0.56) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL3304246 | 0.80 | HDAC3 (0.49) | ALDH1A1MAPTMEN1KMT2AKDM4E | |
| SCHEMBL5544191 | 0.79 | HIF1A (0.45) | ALDH1A1GAAMAPTKDM4ETP53 | |
| SCHEMBL5695121 | 0.78 | ALDH1A1 (0.79) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL5542545 | 0.77 | HSD17B10 (0.53) | MAPTMEN1KMT2APOLB | |
| SCHEMBL4257416 | 0.77 | APLNR (0.67) | ALDH1A1GAAMEN1KMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1322608-B1 | DELTA1-PYRROLINES USED AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2007-05-02 | — | — | EP | claimed |
| US-6995185-B2 | Δ1-pyrrolines used as pesticides | BAYER CROPSCIENCE AG (DE) | 2006-02-07 | — | — | US | claimed |
| US-20040068122-A1 | Delta1-pyrrolines used as pesticides | BAYER CROPSCIENCE AG (DE) | 2004-04-08 | — | — | US | claimed |
| EP-1322608-A1 | DELTA1-PYRROLINES USED AS PESTICIDES | Bayer CropScience AG (DE) | 2003-07-02 | — | — | EP | claimed |
| WO-2002024646-A1 | DELTA1-PYRROLINES USED AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2002-03-28 | — | — | WO | claimed |
| US-4716162-A | BRAIN FUNCTION | SANKYO COMPANY, LIMITED (JP) | 1987-12-29 | — | — | US | claimed |
| WO-2023210623-A1 | HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME | 株式会社エス・ディー・エス バイオテック | 2023-11-02 | — | — | WO | disclosed |
| CN-107098874-B | N- Thioacyl homoserine lactone class compound, preparation method and the application replaced containing phenylurea | 郑州大学 | 2019-04-30 | — | — | CN | disclosed |
| CN-107098874-A | N Thioacyl homoserine lactone classes compound, its preparation method and the application replaced containing phenylurea | 郑州大学 | 2017-08-29 | — | — | CN | disclosed |
| CN-102532162-B | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMA CO LTD | 2015-05-27 | — | — | CN | disclosed |
| WO-2014184071-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014184070-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| WO-1998004542-A1 | CHROMAN DERIVATIVES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-02-05 | — | — | WO | disclosed |
| US-5036080-A | Aldose reductase inhibitor, reduction of complications from diabetes | SANWA KAGAKU KENYUSHO CO., LTD. (JP) | 1991-07-30 | — | — | US | disclosed |
| WO-1989009773-A1 | (d)-6-FLUORO-2,3-DIHYDRO-2',5'-DIOXO-SPIRO[4H-1-BENZOPYRAN-4,4'-IMIDAZOLIDINE]-2-CARBOXAMIDE DERIVATIVES, MANUFACTURING PROCESS AND USE THEREOF | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1989-10-19 | — | — | WO | disclosed |
| EP-0336416-A1 | (d)-6-Fluoro-2,3-dihydro-2',5'-dioxo-spiro[1H-1-Benzopyran-4,4'-imidazolidine]-2-carboxamide derivatives, process for the preparation and use of the derivatives | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1989-10-11 | — | — | EP | disclosed |
| EP-0171217-B1 | FUSED-RING HETEROCYCLIC COMPOUNDS A PROCESS FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL USE | SANKYO COMPANY LIMITED (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4716162-A | BRAIN FUNCTION | SANKYO COMPANY, LIMITED (JP) | 1987-12-29 | — | — | US | disclosed |
| EP-0171217-A2 | Fused-ring heterocyclic compounds a process for their production and their pharmaceutical use | SANKYO COMPANY LIMITED (JP) | 1986-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068122-A1 | Delta1-pyrrolines used as pesticides | DDT, ADRA1D, OPRD1 | ALDH1A1 203/4885GAA 3891/4885MAPT 3155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.